$LLY positioning for next leg up. Eli Lilly showing momentum signals worth watching for entry. GLP-1 franchise continues to drive institutional accumulation. Risk/reward favors longs here if broader pharma sector holds support.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.See T&Cs.